Rogue Stem Cell Clinics Hawking Untested Treatments Irk FDA

May 6, 2019, 2:21 PM UTC

Stem cell clinics selling unproven and potentially dangerous medical treatments for everything from hip pain to Lou Gehrig’s disease face a bigger crackdown from the FDA, the agency’s biologics chief said.

“I’m pretty sure you’ll see ramped-up activity over the next year and half,” Peter Marks, director of the Center for Biologics Evaluation and Research at the Food and Drug Administration, said May 4 at the Association of Health Care Journalists conference. “We want to make sure nobody has mistakes about our intentions to be serious.”

Federal authorities have been going after these stem cell clinics for the past several ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.